Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

DSGNDSGN
Showing 8 of 21 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in DESIGN THERAPEUTICS INC

NORTHERN TRUST CORP holds 353,197 shares of DSGN (DESIGN THERAPEUTICS INC), worth $5.1M as of 2026-Q2. The position was increased (+17.6% shares). DSGN represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$5.1M

Current Shares

353,197

Total Value Change

+$3.3M

Total Shares Change

+16,423

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
353,197
+17.6%
$5.1M0.0%$14.47
31
2026-Q1
Increased
300,279
+4.8%
$3.2M0.0%$10.00
28
2025-Q4
Decreased
286,572
-3.4%
$2.7M0.0%$9.79
0
2025-Q3
Decreased
296,529
-18.2%
$2.2M0.0%$6.85
0
2025-Q2
Decreased
362,518
-3.0%
$1.2M0.0%$3.57
0
2025-Q1
Decreased
373,653
-3.7%
$1.4M0.0%$4.21
0
2024-Q4
Increased
388,125
+15.3%
$2.4M0.0%$6.17
30
2024-Q3
Decreased
336,774
-0.2%
$1.8M0.0%$5.33
0

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used